SEC 13F Intelligence

Bridge City Capital, LLC / PCRX

Bridge City Capital, LLC’s Pacira Biosciences Inc Position

Does Bridge City Capital, LLC own Pacira Biosciences Inc (PCRX)? Yes — 402.8K shares worth $9M (+2.52% of its 13F portfolio) as of Q1 2026, up from 285.5K shares the prior filed quarter.

Position Value
$9M
Q1 2026
Shares
402.8K
% of Portfolio
+2.52%
Quarters Held
9
currently held

Position History PCRX

Reported value by quarter
Q1 ’24: $2MQ1 ’24Q2 ’24: $2MQ3 ’24: $3MQ3 ’24Q4 ’24: $4MQ1 ’25: $4MQ1 ’25Q2 ’25: $4MQ3 ’25: $8MQ3 ’25Q4 ’25: $7MQ1 ’26: $9MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026402.8K$9M+2.52%
Q4 2025285.5K$7M+2.17%
Q3 2025311.4K$8M+2.14%
Q2 2025169.7K$4M+1.14%
Q1 2025172.1K$4M+1.28%
Q4 2024229.2K$4M+1.15%
Q3 2024231.2K$3M+0.96%
Q2 202484.9K$2M+0.82%
Q1 202461.9K$2M+0.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridge City Capital, LLC’s full portfolio or all institutional holders of PCRX.